Agilent Technologies, Inc.

Industrials
Biotechnology: Laboratory Analytical Instruments
www.agilent.com

Earnings Score
Moat Score
Safety Score
Final Score

Market Cap $41.53B
PE 29
Debt $2.93B
Cash $1.78B
EV $42.68B
FCF $1.42B

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	$1.41B
EBIT	$1.53B
ROE	24%
ROA	14%
FCF	$1.42B
Equity	$5.90B
Growth Stability	61%
PE	29.39
PEG	2.1
PB	7.03
P/FCF	29.3
P/S	6.39
Price/Cash	0.04
Debt/Equity	0.5
Debt/FCF	2.07
Net Margins	20%
Gross Margins	54%
Op. Margins	24%
Earnings CAGR	17%
Sales Growth YoY	-6%
Sales Growth QoQ	0%
Sales CAGR	7%
FCF CAGR	11%
Equity CAGR	4%
Earnings Stability	0.58
Earnings Growth YoY	154%
Earnings Growth QoQ	-8%
Earnings CAGR 5Y	14%

Sales CAGR 5Y	7%
FCF CAGR 5Y	17%
Equity CAGR 5Y	6%
Earnings CAGR 3Y	1%
Sales CAGR 3Y	1%
FCF CAGR 3Y	13%
Equity CAGR 3Y	7%
Market Cap	$41.53B
Revenue	$6.50B
Dividend Yield	1%
Payout Ratio	19%
Assets	$11.00B
Total Debt	$2.93B
Cash	$1.78B
Shares Outstanding	287.53M
EV	42.68B
Earnings Score	84%
Moat Score	95%
Safety Score	83%
Final Score	88%
Working Capital	1.87B
Current Ratio	1.78
Gross Profit	$3.53B
Shares Growth 3y	-1%
Equity Growth QoQ	-5%
Equity Growth YoY	6%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

SEC Filings

Direct access to Agilent Technologies, Inc. (A) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Jul 31
- 10-Q Apr 30
- 10-Q Jan 31
2023
- 10-K Oct 31
- 10-Q Jul 31
- 10-Q Apr 30
- 10-Q Jan 31
2022
- 10-K Oct 31
- 10-Q Jul 31
- 10-Q Apr 30
- 10-Q Jan 31

Sector Comparison

How does Agilent Technologies, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Agilent Technologies, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 17%

Stability 58%

loading chart...

Agilent Technologies, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Agilent Technologies, Inc..

Years

Calculation mode

= $31B

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$1.4B	$1.6B	$1.8B	$2B	$2.2B	$2.4B	$2.7B	$3B	$3.4B	$3.7B	$4.2B	$42B
DCF		$1.4B	$1.5B	$1.5B	$1.5B	$1.5B	$1.5B	$1.5B	$1.6B	$1.6B	$1.6B	$16B
Value	$31B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	10/2015	10/2016	10/2017	10/2018	10/2019	10/2020	10/2021	10/2022	10/2023	TTM
Net Margins	10%	11%	15%	6%	21%	13%	19%	18%	18%	20%
ROA	-	11%	12%	12%	11%	10%	13%	15%	13%	14%
ROE	-	11%	14%	7%	23%	15%	22%	24%	21%	24%

Good Net Margins (19.51%)

Net Margins are high enough to offer a good protection on the profits in case of higher costs or higher interests. Furthermore higher margins reduce earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	10/2015	10/2016	10/2017	10/2018	10/2019	10/2020	10/2021	10/2022	10/2023	TTM
Debt over FCF	-	2.92	2.82	1.98	2.78	2.94	2.1	2.71	1.86	2.07
Debt over Equity	0.4	0.45	0.42	0.39	0.51	0.48	0.51	0.52	0.47	0.5
Growth Stability	-	-	-	61%	100%	100%	100%	100%	100%	61%

Neutral Debt/FCF ratio (2.07)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Good Debt/Equity ratio (0.5)

The company is not overleveraged and has a good balance between equity and debt.

Bad Graham’s Stability (61%)

The company has a bad stability in its earnings, which is a sign of a bad competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	10/2015	10/2016	10/2017	10/2018	10/2019	10/2020	10/2021	10/2022	10/2023	CAGR 5Y
Revenue YoY growth	-	4%	6%	10%	5%	3%	18%	8%	-0%	7%
Earnings YoY growth	-	15%	48%	-54%	239%	-33%	68%	4%	-1%	14%
Equity YoY growth	-	2%	14%	-5%	4%	3%	11%	-2%	10%	6%
FCF YoY growth	-	66%	9%	28%	-5%	-7%	62%	-21%	44%	17%